Find a consultant

Our consultant directory offers information on who our consultants are, their specialities and where they are based.

If you have an enquiry relating to your appointment or your treatment, you should contact the relevant department instead of your individual consultant to ensure that our clinical support team can provide you with the right support to your enquiry in a timely manner.

Photo of Dr Jeff Davies

Dr Jeff Davies

Consultant at St Bartholomew's Hospital

Dr Jeff Davies is a Reader in Haemato-oncology at Barts Cancer Institute (BCI), Queen Mary University of London and an honorary Consultant Haematologist at Barts Health NHS Trust specialising in the management of lymphoid malignancies and stem cell transplantation. He qualified from Oxford University and trained in Haematology  in London undertaking a PhD in transplant immunology at UCL receiving  the George Santos Prize form the American Society of Blood and Marrow Transplantation. After undertaking a period of funded postdoctoral research at Harvard he returned to Barts as a clinical senior lecturer and MRC Clinician Scientist, where he now runs a research group at BCI combined with clinical practice at Barts Health NHS Trust.

Dr Davies is the Impact Network centre lead for stem cell transplant trials at Barts Health, is active in the British Society of Blood and Marrow transplantation and attends the national NCRI high grade lymphoma study group . He is an investigator and/or trial monitoring committee member for muliple national and international clinical trials . 

Recently he has led a new service providing stem cell transplantation for patients with Multiple Sclerosis at Barts Health.

Treatments and procedures

  • Chemo-immunotherapy
  • Clinical Trials
  • Stem cell transplantation
     

Research interests

Dr Davies leads a research group in the Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London. His group works on identifying and developing novel approaches to improve efficacy and safety of stem cell transplantation and adoptive immunotherapy as treatments for blood cancers and other diseases. Recently his group have identified the impact of genetic lesions in follicular lymphoma on allogeneic immune responses, tissue-specific immune pathways important in graft-versus-host disease  and used  novel mass cytomety technology to globally profile immune cell reconstitution after stem cell transplantation. He has published over 50 peer-reviewed articles in journals including Science Translational Medicine, Cancer Research and Blood with recent or current research funding from the MRC, CRUK, Blood Cancer UK,  Barts Charity and other sources.

Dr Jeff Davies at Barts Cancer Institute

Leadership roles

  • Impact centre Lead for Barts Health
  • Deputy Director of Stem Cell Transplant Programme, Barts Health
  • Postgraduate Tutor, BCI/QMUL
  • Module lead, Clinical Cancer Treatment MSc, BCI
Speciality
Consultant services Cancer
Languages Spoken English
GMC number 3687444
Record last modified